Recorded Chinese product: 注射用对氨基水杨酸钠注射用对氨基水杨酸钠
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 辽宁倍奇药业有限公司Chinese legal name: 辽宁倍奇药业有限公司
主要成分Active Ingredients
- 对氨基水杨酸钠Duian Jishui Yangsuan Na
药物知识说明
对氨基水杨酸钠是一种在国家药监局注册认定的药品。该药品含有对氨基水杨酸钠-b06e3c26等成分。
该药品关联的活性成分包括：对氨基水杨酸钠Duian Jishui Yangsuan Na。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：辽宁倍奇药业有限公司Chinese legal name: 辽宁倍奇药业有限公司。
您可以探索含有相同成分的其他药品：对氨基水杨酸钠-b06e3c26成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 注射用对氨基水杨酸钠) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 对氨基水杨酸钠Duian Jishui Yangsuan Na.
Manufacturers recorded for this product: 辽宁倍奇药业有限公司Chinese legal name: 辽宁倍奇药业有限公司.
Explore other medicines containing the same ingredient: 对氨基水杨酸钠 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 注射用对氨基水杨酸钠Recorded Chinese product: 注射用对氨基水杨酸钠
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 2g2 g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 辽宁倍奇药业有限公司Chinese legal name: 辽宁倍奇药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H21022193
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H21022193
Manufacturer
Chinese legal name: 辽宁倍奇药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H21022193
生产企业
辽宁倍奇药业有限公司(国产)
适应症
适用于结核分枝杆菌所致的肺及肺外结核病，静滴可用于治疗结核性脑膜炎及急性播散性结核病。本品仅对分枝杆菌有效。单独应用时结核杆菌能迅速产生耐药性，因此本品必须与其他抗结核药合用。链霉素和异烟肼与本品合用时能延缓结核杆菌对前二者耐药性的产生。本品对不典型分枝杆菌无效。主要用作二线抗结核药物。
用法用量
静脉滴注一日4静脉滴注一日4-12g，临用前加灭菌注射―水适量使溶解后再用5%葡萄糖注射液500ml稀释，2-3小时滴完。小儿每日0.2-0.3g/kg。
不良反应
1．发生率较多者：瘙痒皮疹、关节酸痛与发热、极度疲乏或软弱，嗜酸性粒细胞增多(较常见的原因为过敏)。
禁忌
尚不明确。
注意事项
1．交叉过敏反应，对其他水杨酸类包括水杨酸甲酯（冬青油）或其他含对氨基苯基团（如某些磺胺药或染料）过敏的患者对本品亦可呈过敏。
贮藏
遮光，密闭保存。
规格
2g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.